24th week of 2010 patent applcation highlights part 42 |
Patent application number | Title | Published |
20100150781 | Optical sensor and methods for measuring molecular binding interactions - Optical sensor for the measurement of molecular binding interactions. Preferred embodiments provide real-time measurements of kinetic binding and disassociation of molecules including binding and disassociation of protein molecules with other protein molecules and with other molecules. In preferred embodiments ligands are immobilized within pores of a porous silicon interaction region produced in a silicon substrate, after which analytes suspended in a fluid are flowed over the porous silicon region. Binding reactions occur when analyte molecules diffuse closely enough to the ligands to become bound. In preferred embodiments both ligands and analytes are delivered by computer controlled robotic fluid flow control techniques to the porous silicon interaction regions through microfluidic flow channels. | 2010-06-17 |
20100150782 | DISPENSING NOZZLE AND AUTOMATIC ANALYZER - A dispensing nozzle includes a holding tube portion that holds a fluid as a dispensing target; and a discharge end face that is formed at a tip of the holding tube portion and that sucks in and discharges the fluid through an opening formed thereon. The discharge end face has a greater contact angle with the fluid than an inner face of the holding tube portion. | 2010-06-17 |
20100150783 | CHEMICAL REACTION APPARATUS - A chemical reaction apparatus in which a chemical reaction of solutions is carried out by transferring the solutions includes moving units to seal or move the solutions in a flow passage or a plurality of chambers of a container by applying an external force to an elastic body of the container by moving on a surface of the elastic body while the moving units contact with the surface of the elastic body, the moving units being movable independently from each other with respect to a cartridge including the container which is at least partially structured with the elastic body, the container including the plurality of chambers to contain the solutions and the flow passage to connect the plurality of chambers, and a detection unit to detect a state of solution pool in the flow passage or the chamber. | 2010-06-17 |
20100150784 | Device for Dissolving Solid Substances in Water - A device for dissolving solid chemical substances in water is provided with: a container, which has a bottom portion designed to contain an aqueous solution; a perforated loading chamber, which is set at the top of the bottom portion and is designed to contain a solid chemical substance; and a spraying device set within the loading chamber for directing at least one jet of water onto the solid chemical substance. In use, the solid chemical substance is set around the spraying device, and the jet of water is directed downwards and/or laterally so as not to wet the solid chemical substance set above the spraying device. In this way, there is obtained a relatively gradual dissolution of the solid chemical substance and a lower development of gaseous substances having an unpleasant smell. | 2010-06-17 |
20100150785 | SANITIZING DEVICE - A sanitizing device ( | 2010-06-17 |
20100150786 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) - A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal. | 2010-06-17 |
20100150787 | DISPLAY FILTER AND DISPLAY DEVICE REMOVING INDOOR AIR POLLUTANTS - A display filter for a display device having a display module includes a base substrate disposed in front of the display module, at least one optical filter layer layered on the base substrate, and an indoor air purification layer layered on an outwardly exposed side of the display filter and removing indoor air pollutants. | 2010-06-17 |
20100150788 | Apparatus for Regenerating Catalyst - Disclosed is a catalyst distributor and process for spreading catalyst over a regenerator vessel. Nozzles disposed angular to a header of the distributor spread catalyst throughout a full cross section of the catalyst bed. | 2010-06-17 |
20100150789 | SYSTEMS FOR PRODUCING SILICON TETRAFLUORIDE FROM FLUOROSILICATES IN A FLUIDIZED BED REACTOR - Systems for preparing silicon tetrafluoride by the thermal decomposition of an alkali or alkaline earth-metal fluorosilicate. The system includes a drying apparatus for removing moisture from a fluorosilicate feed; a fluidized bed reactor comprising a reaction chamber for thermal decomposition of fluorosilicate into silicon tetrafluoride gas and an alkali or alkaline earth-metal fluoride; a heater apparatus and an exhaust gas treatment system for treating gases discharged from the fluidized bed reactor. | 2010-06-17 |
20100150790 | Catalyzing Lean NOx Filter and Method of Using Same - A NOx trapping filter is provided for use in emission control systems, for example, on the exhaust gas from an internal combustion engine. The NOx trapping filter has a substrate constructed using bonded fiber structures, which cooperate to form a highly uniform open cell network, as well as to provide a uniform arrangement of pores. The substrate typically is provided as a wall-flow honeycomb structure, and in one example, is manufactured using an extrusion process. In this way, the substrate has many channel walls, each having an inlet surface and an outlet surface. The inlet surface has a uniform arrangement of pores that form a soot capture zone, where soot and other particulate matter is captured from an exhaust gas. A NOx adsorber material is disposed in the filter to trap NOx during lean operation of the engine. A NOx conversion catalyst is also disposed inside the channel wall, where NOx and excess hydrocarbons in the exhaust gas are reacted to less harmful substances when the engine system is operated in a rich condition. Because of the uniform pore structure and open cell arrangement inside the channel wall, the filter is capable of being heavily loaded with catalyst, adsorber, while avoiding undue increase in backpressure to the internal combustion engine. | 2010-06-17 |
20100150791 | FIBER MAT CONTAINING AN ORGANOSILICON COMPOUND AND POLLUTION CONTROL DEVICE USING IT - The present invention relates to a fiber mat, preferably a non-intumescent, polycrystalline, needle-punched or stitch-bonded aluminia-silica fiber mat, which contains an organosilicon compound. The fiber mat comprises a fiber blanket which is essentially free of organic binder and which is impregnated with an organosilicon compound selected from the group consisting of siloxane compounds, alkoxy group-containing silanes, hydrolysates and condensates of these compounds, and combinations thereof. In a further embodiment the fiber mat comprises a high friction coating on at least the side of the mat which is to be brought in contact with a pollution control element of a pollution control device. Furthermore, the present invention relates to a pollution control device containing such a fiber mat. | 2010-06-17 |
20100150792 | EXHAUST GAS PURIFYING CATAYST - An exhaust gas purifying catalyst having a good ignition performance is provided. The exhaust gas purifying catalyst | 2010-06-17 |
20100150793 | Combined Labyrinthine Fluid Sterilizing Apparatus - The present invention provides a combined labyrinthine fluid sterilizing apparatus, comprising a chamber having an inlet and an outlet as well as a blower/fan provided in the chamber. Ultraviolet lamps are mounted in the lumen of the chamber. The lumen of the chamber is divided by a plurality of bafflers having pores. The pores in the adjacent bafflers are arranged to stagger up and down or from side to side. A mesh plate is provided at the pore. The top and bottom plates of the chamber can be flipped open. The baffler is inserted in the slots in the inner side of the front and back plates. The top and bottom plates have the pore and a cover plate which are both covered by a shield. At least one of the bafflers has a pore, and is provided with a one-way openable valve. The blower is mounted at the pore of the baffler. The chamber and the bafflers are coated with a layer of titanium dioxide. According to the present invention, it is possible to add, remove, or replace the baffler, the filter mesh, the blower or the purifying accessories and the like. The one-way openable valve can prevent the polluted water or air from flowing backwards. Further the to and fro winding disinfecting and sterilizing path prolongs the disinfecting and sterilizing process and increases the duration. With the photocatalytic effect of titanium dioxide, the organic substances are effectively decomposed, the dirt is eliminated, and deodorization and sterilization achieved. As a result, an ideal effect of disinfection and sterilization is achieved. | 2010-06-17 |
20100150794 | SMALL DISTRIBUTED GASIFICATION UNITS WITH SYNGAS TRANSPORTATION VIA PIPELINE NETWORK FOR BIOMASS TREATMENT - The present invention discloses a system for biomass treatment which addresses the need to find economical solutions to transport biomass. In the present invention, small, distributed gasifiers convert the biomass into synthesis gas (“syngas”). The syngas is then transported via a pipeline network to a central fuel production facility. | 2010-06-17 |
20100150795 | APPARATUS FOR GENERATING MERCURY (II) SULFIDE FROM ELEMENTAL MERCURY - An apparatus is provided for generating mercury (II) sulfide from elemental mercury. Elemental mercury is injected into a heated and sealed reaction vessel containing vaporized sulfur. The elemental mercury reacts with at least a portion of the vaporized sulfur to form the mercury (II) sulfide within the reaction vessel. The formed mercury (II) sulfide is then unloaded from the reaction vessel. | 2010-06-17 |
20100150796 | FUEL REFORMER - A fuel reformer which can easily achieve high weight energy density and high volume energy density, and a method for producing the fuel reformer with ease and high efficiency as well as an electrode for electrochemical device, such as a fuel cell, and an electrochemical device are provided. The present invention is to feed hydrogen obtained from a fuel reformer having a catalyst layer containing Pt for taking out hydrogen from a liquid fuel, such as methanol, and a hydrogen permeable layer, such as a Pd thin film, which is impermeable to liquid and permeable to hydrogen to an electrochemical device such as a fuel cell, which comprises a negative electrode, a positive electrode and a proton conductive film sandwiched therebetween. The present invention provides a method of producing the hydrogen permeable layer in the reformer | 2010-06-17 |
20100150797 | MIXING APPARATUS - To provide a mixing device capable of effectively mixing stock oil with a catalyst promptly and evenly, while increasing the amount of throughput. | 2010-06-17 |
20100150798 | ACTINIDE EXTRACTION METHODS AND ACTINIDE SEPARATION COMPOSITIONS - Methods of separating actinides from lanthanides are disclosed. A regio-specific/stereo-specific dithiophosphinic acid having organic moieties is provided in an organic solvent that is then contacted with an acidic medium containing an actinide and a lanthanide. The method can extend to separating actinides from one another. Actinides are extracted as a complex with the dithiophosphinic acid. Separation compositions include an aqueous phase, an organic phase, dithiophosphinic acid, and at least one actinide. The compositions may include additional actinides and/or lanthanides. A method of producing a dithiophosphinic acid comprising at least two organic moieties selected from aromatics and alkyls, each moiety having at least one functional group is also disclosed. A source of sulfur is reacted with a halophosphine. An ammonium salt of the dithiophosphinic acid product is precipitated out of the reaction mixture. The precipitated salt is dissolved in ether. The ether is removed to yield the dithiophosphinic acid. | 2010-06-17 |
20100150799 | PROCESSES FOR EXTRACTING ALUMINUM AND IRON FROM ALUMINOUS ORES - There are provided processes for extracting aluminum ions from aluminous ores. Such processes can be used with various types of aluminous ores such as aluminous ores comprising various types of metals such as Fe, K, Mg, Na, Ca, Mn, Ba, Zn, Li, Sr, V, Ni, Cr, Pb, Cu, Co, Sb, As, B, Sn, Be, Mo, or mixtures thereof. | 2010-06-17 |
20100150800 | Oxidation catalyst and exhaust-gas purification system using the same - An oxidation catalyst that efficiently promotes oxidation of NO to NO | 2010-06-17 |
20100150801 | FORMED CATALYST FOR NOx REDUCTION - The present invention provides a formed catalyst comprising a binder, a zeolite, and a catalytic metal disposed on a porous inorganic material. The zeolite domains in the formed catalyst are substantially free of the catalytic metal which is disposed on and or within the porous inorganic material. The formed catalyst is in various embodiments an extrudate, a pellet, or a foamed material. In one embodiment, the catalytic metal is silver and the porous inorganic material is γ-alumina. The formed catalysts provided are useful in the reduction of NOx in combustion gas streams. | 2010-06-17 |
20100150802 | PROCESSING CO2 UTILIZING A RECIRCULATING SOLUTION - In some embodiments, the invention provides, a method comprising a) contacting a solution with an industrial source of carbon dioxide to produce a CO | 2010-06-17 |
20100150803 | METHOD FOR CAPTURING CARBON DIOXIDE - A method for capturing carbon dioxide has been disclosed in the invention, comprising the steps of: (1) electrolyzing a saturated salt solution so as to obtain sodium hydroxide; (2) adding the sodium hydroxide into a seawater solution, so as to allow magnesium chloride and calcium chloride in the seawater to be converted into magnesium hydroxide and calcium hydroxide; (3) bringing carbon dioxide into a water solution having magnesium hydroxide and calcium hydroxide, so as to convert them into magnesium carbonate and calcium carbonate. The method allows for the capture of carbon dioxide in an effective, fast and safe manner, which reduces the amount of atmospheric carbon dioxide, and cuts down carbon dioxide emissions consequently. | 2010-06-17 |
20100150804 | Carbon Dioxide Scrubbing Using Ionic Materials - One aspect of the present invention relates to amine-functionalized task-specific ionic liquids (TSILs). In certain embodiments, the ionic liquids of the invention comprise beta-hydroxy amines, aryl amines or tertiary amines. The TSILs may be used for gas capture, capitalizing on their non-volatile nature. In certain embodiments, the captured gas is selected from the group consisting of CO | 2010-06-17 |
20100150805 | HIGHLY STABLE AND REFRACTORY MATERIALS USED AS CATALYST SUPPORTS - This invention involves highly porous, stable metal oxide felt materials that are used as catalytic supports for a number of different applications including dehydrogenation of light paraffins to olefins, selective hydrogenation of dienes to olefins, hydrogenation of carboxylic acids, oxidation or ammoxidation reactions, epoxidation of light olefins and removal of sulfur compounds from gas streams. | 2010-06-17 |
20100150806 | CALCIUM PHOSPHATE GRANULES OF THE HYDROXYAPATITE TYPE, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS - The invention concerns calcium phosphates in granular form having an x-ray diffraction pattern characteristic of hydroxyapatite and good compressibility and flow properties in direct compression applications. The invention also concerns the method for preparing said granules characterized in that it comprises processing a suspension of brushite dicalcium phosphate having a certain particle-size distribution using a basic solution, and maintaining the pH at not less than 7.0 for a sufficient time interval to enable the transformation of the brushite calcium phosphate into hydroxyapatite calcium phosphate. | 2010-06-17 |
20100150807 | APPARATUS FOR PREPARING CA-P BIOMATERIAL BY PURIFICATION METHOD OF DIALYSIS AND SEPARATION - An apparatus for preparing Ca—P biomaterial by purification method of dialysis and separation is provided. The apparatus comprises a synthesis reactor( | 2010-06-17 |
20100150808 | PROCESSES FOR PRODUCING SILICON TETRAFLUORIDE FROM FLUOROSILICATES IN A FLUIDIZED BED REACTOR - Processes for preparing silicon tetrafluoride by the thermal decomposition of an alkali or alkaline earth-metal fluorosilicate in a fluidized bed reactor. A portion of silicon tetrafluoride that is generated in the decomposition reaction may be recycled to the reactor and used as a fluidizing gas to suspend the fluorosilicate material. Alkali or alkaline earth-metal fluoride residue generated in the decomposition reaction may be discharged from the reactor and reacted with fluorosilicic acid to produce an alkali or alkaline earth-metal fluorosilicate that may be introduced to the reactor for further generation of silicon tetrafluoride. | 2010-06-17 |
20100150809 | ENHANCEMENTS FOR A CHLOROSILANE REDISTRIBUTION REACTOR - The present invention includes a process and means for using two isolated by-products from the reaction of at least one of metallurgical silicon and silicon tetrachloride with at least one of anhydrous hydrogen chloride and hydrogen to produce trichlorosilane. The two isolated by-products are dichlorosilane and silicon tetrachloride. The present process reduces chlorosilane waste and improves efficiency of overall process for production of trichlorosilane for use in chemical vapor deposition of polysilicon for electronic and solar applications. The present invention further includes a chemical reactor for the reacting dichlorosilane with silicon tetrachloride to produce additional trichlorosilane. | 2010-06-17 |
20100150810 | Method of coproducing methanol and ammonia - The present invention enables the coproduction of methanol and ammonia by using a remarkably smaller amount of raw material, natural gas, as compared with the case of independently producing either of methanol or ammonia. Specifically, the present invention provides a process of coproducing methanol and ammonia by using natural gas, LPG, butane, or naphtha as raw material, having a methanol production process (A) composed of specific steps and an ammonia production process (B) also composed of specific steps, in which (1) directing a gas rich in hydrogen recovered in a hydrogen recoverying step in the methanol production process (A) to a certain step after an air reforming step and before a ammonia synthesis step in the ammonia production process (B) to prepare additional feedstock gas for ammonia synthesis; and also (2) cooling a synthesis gas, formed in a steam reforming step in the methanol production process (A) and separating and removing condensed water from the cooled synthesis gas, mixing the water removed synthesis gas and carbon dioxide obtained by pre-compressing carbon dioxide obtained in a CO | 2010-06-17 |
20100150811 | Preparation of Nanosized Copper (I) Compounds - A method of making nanosized copper (I) compounds, in particular, copper (I) halides, pseudohalides, and cyanocuprate complexes, in reverse micelles or microemulsions is disclosed herein. The method of the invention comprises (a) dissolving a copper (II) compound in the polar phase of a first reverse micelle or microemulsion, (b) dissolving a copper (II) to copper (I) reducing agent or a pseudohalide salt in the polar phase of a second sample of the same reverse micelle or microemulsion, (c) mixing the two reverse micelle/microemulsions samples to form nanometer sized copper (I) compounds and (d) recovering said nanometer sized copper (I) compounds. The present invention is also directed to the resultant nanosized copper (I) compounds, such as copper (I) chloride, copper (I) cyanide, and potassium cyanocuprate complexes having an average particle size of about 0.1 to 600 nanometers. | 2010-06-17 |
20100150812 | INDIRECTLY HEATED TEMPERATURE CONTROLLED ADSORBER FOR SORBATE RECOVERY - Systems and processes are provided that relate to the recovery of sorbates in processes utilizing temperature controlled adsorption. Sorbate recovery can include providing a temperature controlled adsorber that is undergoing a regeneration cycle after undergoing an adsorption cycle. The temperature controlled adsorber can have one or more adsorption flow passages and one or more heat transfer flow passages. The one or more adsorption flow passages can contain an adsorptive material coating with a sorbate adsorbed thereto. A heating fluid can be provided to the one or more heat transfer flow passages of the temperature controlled adsorber. A regeneration stream can be provided to the one or more adsorption flow passages of the temperature controlled adsorber. The adsorptive material coating can be regenerated by removing the sorbate from the temperature controlled adsorber to produce a regeneration effluent stream. | 2010-06-17 |
20100150813 | Method And Apparatus For Producing Carbon Monoxide By Cryogenic Distillation Using A Distillation Column System Supplied With A Mixture Of Which The Main Components Are At Least Hydrogen And Carbon Monoxide - A method and apparatus for producing carbon monoxide by cryogenic distillation is presented. | 2010-06-17 |
20100150814 | Methods For Forming Activated Carbon Material For High Energy Density Ultracapacitors - A method for producing an activated carbon material includes forming an aqueous mixture of a natural, non-lignocellulosic carbon precursor and an inorganic compound, heating the mixture in an inert or reducing atmosphere, cooling the heated mixture to form a first carbon material, and removing the inorganic compound to produce an activated carbon material. The activated carbon material is suitable to form improved carbon-based electrodes for use in high energy density devices. | 2010-06-17 |
20100150815 | METHOD AND APPARATUS FOR THE CONTINUOUS PRODUCTION OF CARBON NANOTUBES - The present invention relates to an apparatus for the continuous production of carbon nanotubes (CNT), as well as the method to carry it out. The apparatus for the CNT synthesis includes: two sets or more of tubes to synthesize in its interior the CNT; a set of nozzles for the same number of tubes that each set has, to feed to the interior of the tubes the precursory chemical compounds of the CNT; a furnace to maintain one of the sets to a suitable temperature to allow the formation of the CNT inside the tubes; a system for the detaching and collection of the CNT formed in the previous stage; and a control system, preferably a PLC (PLC by its abbreviation in English) to program the sequence of activities of the equipment. | 2010-06-17 |
20100150816 | Methods for Purifying an Aqueous Hydrochloric Acid Solution - Methods for purifying an aqueous hydrochloric acid solution waste stream having an impurity fraction comprising an initial Ti fraction, an initial S fraction and an initial Si fraction; that provide purified aqueous hydrochloric acid solutions having a final Ti fraction of less than 250 ppm, a final S fraction of less than 200 ppm, and a final Si fraction of less than 10 ppm, which may be determined with inductively coupled plasma spectroscopy. Process steps in various embodiments include sparging with an gas; mixing the sparged solution with a precipitation agent comprising a sufficient amount of an alkali earth metal salt and, optionally, a phosphoric acid source, to provide a metal salt precipitate; and mixing the initial aqueous acid solution or, optionally, the sparged aqueous acid solution, with a flocculating polymer. A preferred alkali earth metal salt is barium chloride and preferred flocculating polymers are poly(diallyldialkylammonium chloride) homopolymers and copolymers. | 2010-06-17 |
20100150817 | METHOD FOR GENERATING MICRONIZED SULPHUR - A method of producing micronized sulphur wherein elemental sulphur is dissolved in a solvent for sulphur to produce a sulphur-solvent solution and precipitation of the dissolved sulphur is effected or controlled by manipulation of at least one of pressure, temperature or water content in the solvent to produce the micronized sulphur. | 2010-06-17 |
20100150818 | Clarification of water and wastewater - A process and method for liquid-solid separation in raw water by chemical treatment, comprising adding into the water, separately or together, an effective amount of at least one aluminum polymer with an effective amount of an ammonium polymer, including at least one medium, high, or very high molecular weight ammonium polymer, to clarify said raw water to a settled turbidity standard, and including methods for blending and storing solution polymers. | 2010-06-17 |
20100150819 | TITANIUM DIOXIDE HAVING INCREASED SINTERING ACTIVITY - A crystalline titanium dioxide powder, containing aggregated primary particles, wherein a BET surface area of the aggregated primary particles is from 30 to 65 m | 2010-06-17 |
20100150820 | Process for Producing Enhanced Alumina - The present invention provides an essentially dry method for preparation of enhanced alumina powders. The first step involves rapid calcination of an aluminum compound to produce alumina powder. The alumina powder is mixed with solid ammonium carbonate and a small amount of water. This mixture heats itself although some external heat is helpful to produce ammonium aluminum hydroxycarbonate (dawsonite-type) NH | 2010-06-17 |
20100150821 | Process and Apparatus for Generating Hydrogen - A solution is to be created, with a method and a device for generating hydrogen, in which silicon and/or an alloy that contains silicon is reacted in a reaction vessel ( | 2010-06-17 |
20100150822 | PULVERULENT INTERMETALLIC MATERIALS FOR THE REVERSIBLE STORAGE OF HYDROGEN - The present invention relates to pulverulent materials suitable for storing hydrogen, and more particularly to a method of preparing such a material, in which: (A) a composite metallic material having a specific granular structure is prepared by co-melting the following mixtures: a first metallic mixture (m1), which is an alloy (a1) of body-centred cubic crystal structure, based on titanium, vanadium, chromium and/or manganese, or a mixture of these metals in the proportions of the alloy (a1); and a second mixture (m2), which is an alloy (a2), comprising 38 to 42% zirconium, niobium, molybdenum, hafnium, tantalum and/or tungsten and 56 to 60 mol % of nickel and/or copper, or else a mixture of these metals in the proportions of the alloy (a2), with a mass ratio (m2)/(m1+m2) ranging from 0.1 wt % to 20 wt %; and (B) the composite metallic material thus obtained is hydrogenated, whereby the composite material is fragmented (hydrogen decrepitation). | 2010-06-17 |
20100150823 | IRON PROMOTED NICKEL BASED CATALYSTS FOR HYDROGEN GENERATION VIA AUTO-THERMAL REFORMING OF ETHANOL - A composition for catalyzing the auto-thermal reformation of ethanol, including a porous refractory substrate with a nickel-iron-aluminum oxide material at least partially filling the pores. The substrate is typically an alumina-based ceramic, such as gamma alumina or mullite. The catalyst composition is typically produced by identifying a refractory substrate having a relatively high surface area, such as through the existence of a pore network, infiltrating the refractory substrate with iron oxide and nickel oxide precursors, and combining the iron oxide and nickel oxide precursors with aluminum oxide to form a hybrid nickel-iron-aluminum oxide material at least partially coating the refractory substrate. | 2010-06-17 |
20100150824 | HYDROGEN GENERATOR WITH REACTANT DILUTION SCHEME - A hydrogen generator ( | 2010-06-17 |
20100150825 | Method for effectively controlling the temperature of oxide-coated short-channel-length metallic structures - A method for the partial oxidation of hydrocarbons is provided wherein an endothermic catalyst and an oxidation catalyst are positioned upon a short channel-length metallic substrate; the endothermic catalyst positioned under a surface layer of the oxidation catalyst positioned on the metallic substrate. A fuel-rich supply of hydrocarbons and oxygen is then passed over the substrate. The method includes providing an oxidation catalyst on at least a portion of a surface of the metallic substrate wherein a hydrocarbon is oxidized by an oxygen mass-transfer-limited reaction on the oxidation catalyst surface; and providing an endothermic catalyst on the metallic substrate below the oxidation catalyst surface whereby an endothermic reaction follows the oxygen mass-transfer-limited reaction below the oxidation catalyst surface. | 2010-06-17 |
20100150826 | MICROPOROUS METALS AND METHODS FOR HYDROGEN GENERATION FROM WATER SPLIT REACTION - The present invention relates to hydrogen generating microporous metals, methods for preparing microporous metals, and methods for producing hydrogen from water using the metals and systems of the invention. In particular, microporous metals selected from the group comprising aluminum (Al), magnesium (Mg), silicon (Si), Iron (Fe) and zinc (Zn), capable of producing hydrogen upon reaction of the metal with water having a neutral pH are provided. Methods for preparing microporous metals comprising the steps of selecting a metal that is sufficiently electropositive (i.e. water reactive); and introducing microporosity in the selected metal by means of mechanical deformation, or metallurgical techniques, in order to generate the microporous metal are also provided, as is a method for producing hydrogen comprising reacting a microporous metal powder with water at a pH of between 4 and 10. | 2010-06-17 |
20100150827 | PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER - The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer. | 2010-06-17 |
20100150828 | RADIOACTIVE GOLD NANOPARTICLES AND METHODS OF MAKING AND USING THEM - Methods of preparing a composition comprising non-ionic, radioactive gold nanoparticles (R-GNPs) are disclosed. The method comprises: a) providing a solution comprising gold (Au-197) ions; and b) exposing the solution to neutron irradiation to generate a composition comprising non-ionic R-GNPs. Alternatively, the method comprises: a) providing a solution that comprises a composition comprising gold (Au-197) nanoparticles (GNPs); and b) exposing the GNP solution to neutron irradiation to generate a composition comprising non-ionic R-GNPs. Compositions that comprises non-ionic R-GNPs encapsulated within and/or anchored to MSNs, and methods of making the same are also disclosed. | 2010-06-17 |
20100150829 | Antibodies to IL-6 and use thereof - The present invention is directed to therapeutic methods using IL-6 antagonists such as an Ab1 antibody or antibody fragment having binding specificity for IL-6 to prevent or treat disease or to improve survivability or quality of life of a patient in need thereof. In preferred embodiments these patients will comprise those exhibiting (or at risk of developing) an elevated serum C-reactive protein level, reduced serum albumin level, elevated D-dimer or other coagulation cascade related protein(s), cachexia, fever, weakness and/or fatigue prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, and others. | 2010-06-17 |
20100150830 | METHOD OF TREATING CANCER - A method and composition for administering a therapeutic agent to a lesion comprising a contrast/carrier agent and ethanol. | 2010-06-17 |
20100150831 | MODULATORS OF CXCR7 - Compounds having formula I, | 2010-06-17 |
20100150832 | BIODEGRADABLE POLYKETAL POLYMERS AND METHODS FOR THEIR FORMATION AND USE - The present invention relates to biodegradable biocompatible polyketals, methods for their preparation, and methods for treating animals by administration of biodegradable biocompatible polyketals. In one aspect, a method for forming the biodegradable biocompatible polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a reducing agent to form the biodegradable biocompatible polyketal. The resultant biodegradable biocompatible polyketals can be chemically modified to incorporate additional hydrophilic moieties. A method for treating animals includes the administration of the biodegradable biocompatible polyketal in which biologically active compounds or diagnostic labels can be disposed. The present invention also relates to chiral polyketals, methods for their preparation, and methods for use in chromatographic applications, specifically in chiral separations. A method for forming the chiral polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a suitable reagent to form the chiral polyketal. A method for use in chiral separations includes the incorporation of the chiral polyketals in the mobile phase during a chromatographic separation, or into chiral stationary phases such as gels. The present invention further relates to chiral polyketals as a source for chiral compounds, and methods for generating such chiral compounds. | 2010-06-17 |
20100150833 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES - The present invention provides compounds and amyloid probes thereof that allow for an antemortem method of diagnosing AD and quantitating the extent or progression of amyloid deposits (plaques) by in vivo imaging of amyloid and/or amyloid deposits in the regions of the brain. Preferably, an amyloid probe of the invention can cross the blood-brain barrier and distinguish AD brain from normal brain. An amyloid probe can be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits. Amyloid probes of the invention can also be used to detect and quantitate amyloid deposits in diseases including, without limitation, Down's syndrome, familial AD and homozygotes for the apolipoprotein E4 allele. In one aspect, the compounds may be used in the treatment or prophylaxis of diseases that include, without limitation, AD and type 2 diabetes mellitus. The compounds and amyloid probes of the invention include analogs, salts, pharmaceutical compositions, derivatives, prodrugs, racemic mixtures or tautomeric forms thereof. | 2010-06-17 |
20100150834 | HIGH AFFINITY EPHB RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF - The present invention provides peptide-based compounds that selectively bind to a member(s) of the EphB receptor family, including, but not limited to, EphB1, EphB2, EphB3, EphB4, EphB5 and EphB6. In particular, the invention provides multimeric peptides that selectively bind to EphB receptors. The present invention also provides compositions, including pharmaceutical compositions, comprising the EphB receptor binding compounds and a pharmaceutically acceptable carrier or excipient. Methods for identifying compounds that selectively or specifically bind to a member of the EphB receptor family are also provided. | 2010-06-17 |
20100150835 | Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate - The present invention discloses the reactivity of ponytail (“PT”) sulfonates as leaving groups in nucleophilic fluorination reactions. The results showed that using a pentafluorobenzenesulfonate precursor is a suitable leaving group for n. c. a. nucleophilic | 2010-06-17 |
20100150836 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING - Fluoroalkoxybenzamide compounds which selectively bind Sigma-2 receptors are disclosed. These compounds, when labelled with | 2010-06-17 |
20100150837 | ANTIBODIES AGAINST GPIb alpha - This application relates to agents capable of specifically recognizing GPIbα, a key receptor required for platelet adhesion and aggregation. More specifically, this application relates to monoclonal antibodies and derivatives thereof capable of specifically recognizing both the murine and the human GPIbα. These monoclonal antibodies and derivatives are particularly useful in the treatment or prevention of thrombosis as well as research tools. | 2010-06-17 |
20100150838 | METHODS FOR EVALUATING OSTEOARTHRITIS RISK - Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs. | 2010-06-17 |
20100150839 | Compositions and Methods for Modulating Cognitive Function - The present invention provides compositions and methods for modulating, e.g., enhancing, cognitive function. The methods involve modulation of translation, modulation of a MAPK signaling pathway, or both. The invention further provides screening methods useful in identifying compounds that modulate, e.g, enhance, cognitive function. The invention further provides method of treating a subject to modulate cognitive function. | 2010-06-17 |
20100150840 | Small-molecule agonists for type-2 orexin receptor - Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag. | 2010-06-17 |
20100150841 | Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation - As described below, the present invention features compositions and methods for increasing TNFR2/p75 receptor signaling to reduce inflammation. Methods for increasing TNFR2/p75 expression or signaling may also be used to increase the survival of resident cells or transplanted stem cells (e.g., bone marrow derived or peripheral blood derived stem cells) in a damaged tissue. | 2010-06-17 |
20100150842 | Method and Kit for Detecting Resistance in Living Organisms - The present invention concerns the detection of resistance in a living organism, e.g., herbicide resistance in weed crops. Based on non-separated compounds obtained from an organism, e.g., an extract from a plant, a color development is generated. The color or shade developed is dependent on the compounds of the organism. By comparing the color or shade of the extract obtained from an organism with a standard color scale developed with respect to the same organism, it is possible to determine if the organism is resistant to a pesticide, e.g., a herbicide. The invention also concerns a method of providing a standard color scale for material from a living organism that has been exposed to stress, e.g., a pesticide. As assay kit for the determination of whether material from a living organism is resistant to a pesticide is also described. The present invention may be used by farmers or advisors to test if the plants have developed resistance to a herbicide. | 2010-06-17 |
20100150843 | PEPTIDE IMAGING AGENTS - The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with an optical reporter group suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC). | 2010-06-17 |
20100150844 | USE OF 8-QUINOLINOL AND ITS ANALOGS TO TARGET CANCER STEM CELLS - 8-quinolinol (8Q) and derivatives thereof for use in the treatment of proliferative diseases such as cancer, in particular slow metabolizing quiescent cancer stem cells. | 2010-06-17 |
20100150845 | SYSTEM AND METHOD FOR THE DELIVERY OF A SANITIZING FOAM - A spray solution generates a foam to sanitize surfaces. The spray dip solution is a mixture of the solution with carbon dioxide and nitrous oxide in a closed vessel. After ejecting the liquid dip solution mixture from a nozzle a foam is generated from the solution as the solution hits a surface. The spray can be applied to a number of different surfaces. In an embodiment of the invention, the spray can be applied to cow teats without risk of cross-contamination of the nozzle or other equipment. The generated foam remains intact on the teat for a prolonged period of time, increases the area of the teat in contact with the foam during the treatment period and disperses skin-conditioning fats present in the dip treatment, thereby increasing the coverage of the skin conditioner on and within the epidermis of the teat and surrounding areas. | 2010-06-17 |
20100150846 | Method of Making Oral Care Compositions with Fused Silica Slurries - A method of making an oral care composition comprising the addition of a fused silica slurry. | 2010-06-17 |
20100150847 | THERAPEUTIC DENTAL COMPOSITION AND RELATED METHODS - Dental compositions are provided comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof: wherein n is an integer from about 2 to about 5. | 2010-06-17 |
20100150848 | Oral Care Compositions with Chelants and Fused Silica - An oral care composition comprising a fused silica abrasive and a chelant. | 2010-06-17 |
20100150849 | Oral Care Compositions - An oral care composition comprising a copolymer of an alkyl vinyl ether and maleic acid or anhydride, a surface active vegetable gum, and a non-cationic antibacterial agent. The composition exhibits increased uptake and retention of the non-cationic antibacterial agent on application to teeth. | 2010-06-17 |
20100150850 | DISPERSION, GEL AND EMULSIFICATION SYSTEM - A dispersion which contains particles of a carboxylic acid polymer dispersed in an organic medium containing an emollient ester and/or a non-ionic surfactant. The dispersion can be used to form a gel composition by mixing with a water miscible emollient ester and optionally water. The dispersion and gel can be used to form an emulsification system. The dispersion, gel and emulsification system are suitable for use in forming end-use emulsions, preferably at low temperature and low shear, and in particular, emulsions having a high oil phase concentration. The emulsions can be used in a wide range of applications, including personal care, household and industrial. | 2010-06-17 |
20100150851 | ANIONIC-CATIONIC COMPLEXES AS CONDITIONING AGENTS - Novel compositions comprising anionic-cationic complexes as conditioning agents for use in products that improve the appearance and feel of skin and hair are well known. This invention describes the use of additional cationic surfactant in combination with an anionic-cationic complex made from a fatty alkyl dialkylamine and a “dicarboxylic acid”, preferably a dimer acid. This combination provides exceptional conditioning for hair, improving both wet and dry combing. It also makes very stable oil-in-water emulsions, and adds a slippery feel and lubricity to shaving and skin cleaning products. | 2010-06-17 |
20100150852 | Process for manufacturing of high surface area USP grade nano-anatase base - The present invention provides a novel manufacturing process for producing a high surface area USP grade titanium dioxide in the nano-anatase form. In a manufacturing method aspect of the present invention, a process of producing a high surface area USP grade TiO | 2010-06-17 |
20100150853 | Artificially coloring the skin with a carotene compound, a xanthophyll compound and a lipophilic green dye composition - A method for artificially coloring the skin entails topical application thereon of a composition containing, formulated into a physiologically acceptable medium:
| 2010-06-17 |
20100150854 | POLYETHYLENE GLYCOL ESTERS AND COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS - The invention relates to polyethylene glycol esters and blends of the polyethylene glycol esters with polyethylene glycol ethers, together with in particular cosmetic and/or dermatological preparations containing them, methods for the production thereof and use thereof. | 2010-06-17 |
20100150855 | Hydroxyl compound and a cosmetic comprising the same - There are provided a novel hydroxyl compound having proper hydroxyl values which exhibits not only excellent moisturizing ability and emollient ability when it is blended in cosmetics, but also, among others, excellent gloss-holding ability, and a cosmetic comprising said hydroxyl compound. A hydroxyl compound obtained by reacting a di- or higher-valent alcohol with a monovalent carboxylic acid to obtain an ester compound, which is then reacted with dimer acid, characterized in that the di- or higher-valent alcohol is diglycerin, and the monovalent carboxylic acid is a carboxylic acid having 5 to 10 carbon atoms, and a molar ratio among diglycerin, the carboxylic acid having 5 to 10 carbon atoms and dimer acid is 1.0:1.5 to 1.6:0.4 to 0.6. | 2010-06-17 |
20100150856 | STABILIZED AQUEOUS ALUMINUM ZIRCONIUM SOLUTIONS - The present invention describes a method and compositions by which introducing PO | 2010-06-17 |
20100150857 | COMPOSITION COMPRISING AT LEAST ONE ORTHO-DIPHENOL, METAL SALT, HYDROGEN PEROXIDE AND (BI)CARBONATE AND HAIR DYEING METHOD THEREWITH - The disclosure relates to a method for dyeing keratinous fibers by applying, to said fibers, i) at least one entity chosen from ortho-diphenol and derivatives thereof, ii) at least one metal salt, iii) hydrogen peroxide or at least one system which generates hydrogen peroxide, and iv) at least one (bi)carbonate, wherein the method for coloring keratinous fibers is carried out in at least two stages, and wherein the at least one (bi)carbonate and the at least one metal salt are applied in separate stages. The disclosure also relates to a ready-to-use cosmetic composition comprising i) at least one entity chosen from ortho-diphenol and derivatives thereof, ii) at least one metal salt, iii) hydrogen peroxide or at least one system which generates hydrogen peroxide, iv) at least one (bi)carbonate, and water in an amount greater than or equal to 50% by weight of the total weight of the composition. The disclosure also relates to a multicompartment device comprising from 2 to 5 compartments comprising from 2 to 5 compositions in which the ingredients i) at least one entity chosen from ortho-diphenol and derivatives thereof, ii) at least one metal salt, iii) hydrogen peroxide or at least one system which generates hydrogen peroxide, iv) at least one (bi)carbonate, and water are distributed, the water being present in at least one of the 2 to 5 compositions, the other 1 to 4 compositions being aqueous or pulverulent, and the water being present in a total amount greater than or equal to 50% by weight of the total weight of the 2 to 5 compositions. | 2010-06-17 |
20100150858 | Hair Conditioning Composition Comprising Cationic Surfactant System and Direct Dye - Disclosed is a hair conditioning composition comprising: a cationic surfactant system of either (i) or (ii): (i) the system comprising: a salt of a mono-long alkyl quaternized ammonium and an anion wherein the anion is selected from the group consisting of C1-C4 alkyl sulfate, and mixtures thereof; and a di-long alkyl quaternized ammonium salt; or (ii) the system comprising: salts of mono-long alkyl amines wherein the mono-long alkyl group has 20 to about 24 carbon atoms; and a di-long alkyl quaternized ammonium salt; a high melting point fatty compound; a direct dye; and an aqueous carrier. The composition of the present invention provides improved coloring benefits, while providing conditioning benefits | 2010-06-17 |
20100150859 | METHODS OF PREPARING METAL-MODIFIED SILICA NANOPARTICLES - A method of preparing metal-modified silica particles is disclosed. Specifically, a treatment chamber is provided in which a first and a second formulation are ultrasonically mixed to prepare metal-modified silica particles. The treatment chamber has an elongate housing through which the first and second formulations flow longitudinally from a first inlet port and a second inlet port, respectively, to an outlet port thereof. An elongate ultrasonic waveguide assembly extends within the housing and is operable at a predetermined ultrasonic frequency to ultrasonically energize the formulations within the housing. An elongate ultrasonic horn of the waveguide assembly is disposed at least in part intermediate the inlet and outlet ports, and has a plurality of discrete agitating members in contact with and extending transversely outward from the horn intermediate the inlet and outlet ports in longitudinally spaced relationship with each other. The horn and agitating members are constructed and arranged for dynamic motion of the agitating members relative to the horn at the predetermined frequency and to operate in an ultrasonic cavitation mode of the agitating members corresponding to the predetermined frequency and the formulations being mixed in the chamber. | 2010-06-17 |
20100150860 | RECOMBINANT CHIMERIC PROTEIN OF NEUTROPHIL INHIBITORY FACTOR AND HIRUGEN, AND PHARMACEUTICAL COMPOSITION THEREOF - Provided is a chimeric protein comprising neutrophil inhibitory factor, the peptide FRRP specially recognizing the thrombin active site and hirugen. Also provided is a pharmaceutical composition comprising the chimeric protein, which can be used for treating or preventing cerebral injury and cerebral edema, inhibiting platelet aggregation etc. | 2010-06-17 |
20100150861 | COMPOSTIONS WITH ENHANCED BIOAVAILABILITY AND FAST ACTING INHIBITOR OR GASTRIC ACID SECRETION - The present invention relates to the use of pharmaceutically acceptable zinc salts, preferably water soluble zinc salts alone or optionally, in combination with one or more of a protein pump inhibitor (PPI), H2 blocker, anti- | 2010-06-17 |
20100150862 | METHODS OF MODULATING MATERNAL-FETAL TOLERANCE - Provided are cytokines and methods of modulating maternal tolerance of a fetus using IL-27 agonists. Also provided are methods of modulating implantation of an embryo to a uterine lining, and methods of diagnosis. | 2010-06-17 |
20100150863 | HYDROXY METHYL PHENYL PYRAZOLYL UREA COMPOUND USEFUL IN TREATMENT OF CANCER - The compound 4-{4-[({3-tert-Butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-carbamoyl)amino]-3-chlorohenoxy}-N-methylpyridine-2-carboxamide and alternatives forms thereof (e.g., salts, hydrates, solvates, prodrugs, polymorphs and metabolites); pharmaceutical compositions which contain them and methods for treating cancer using them. | 2010-06-17 |
20100150864 | ANTIBODIES THAT BIND TO IL-18 AND METHODS OF PURIFYING THE SAME - Anti-IL-18 antibodies are disclosed herein, including antigen-binding portions thereof. One or more methods for isolating and purifying anti-IL-18 antibodies from a sample matrix is presented. These isolated anti-IL-18 antibodies can be used in a clinical setting as well as in research and development. Pharmaceutical compositions comprising isolated anti-IL-18 antibodies are also described. | 2010-06-17 |
20100150865 | NOVEL FORMULATIONS TO INHIBIT CYCLOOXYGENASE AND PRO-INFLAMMATORY CYTOKINE MEDIATED DISEASES - The invention provides method and composition for alleviating one or more symptoms associated with a medical condition mediated by one or more of a cyclooxygenase, a pro-inflammatory cytokine, and a pro-inflammatory enzyme. The method includes administering an effective amount of a composition to a person suffering from the medical condition. The composition essentially includes a set of plant extracts. The set of plant extracts include an extract of | 2010-06-17 |
20100150866 | Hepatitis C Virus Inhibitors - Hepatitis C virus inhibitors having the general formula | 2010-06-17 |
20100150867 | USE OF ALPHA-GLUCOSIDASE INHIBITORS TO TREAT ALPHAVIRUS INFECTIONS - The present invention provides methods for treating a flavivirus infection, including hepatitis C virus (HCV) infection, in an individual suffering from a flavivirus infection. In some embodiments, the methods involve administering to an individual in need thereof an effective amount of an agent that inhibits enzymatic activity of a membrane-bound α-glucosidase inhibitor. In other embodiments, the methods involve administering to an individual in need thereof effective amounts of an α-glucosidase inhibitor and at least one additional therapeutic agent. | 2010-06-17 |
20100150868 | Methods of Individually Optimizing Treatment for an Inflammation Associated Disease - A method of individually optimizing a treatment for an inflammation associated disease is provided. The method comprising contacting each of identical white blood cell samples of a subject in need thereof with a different pharmaceutical agent of a plurality of pharmaceutical agents for the inflammation associated disease, so as to allow elicitation of an anti-inflammatory activity in the white blood cell samples; assaying the anti-inflammatory activity in the white blood cell samples; and identifying a pharmaceutical agent of the plurality of pharmaceutical agents eliciting a strongest anti-inflammatory activity, the pharmaceutical agent being the individually optimized treatment for the inflammation associated disease, wherein when the inflammation associated disease is multiple sclerosis the white blood cell samples are inflamed white blood cell samples. Methods of treating an inflammation associated disease are also described. | 2010-06-17 |
20100150869 | USE OF TELLURIUM COMPOUNDS FOR TREATMENT OF BASAL CELL CARCINOMA AND/OR ACTINIC KERATOSIS - Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided. | 2010-06-17 |
20100150870 | METHOD FOR IMPROVING THE SKIN AND COAT OF PETS - A method for improving or maintaining the skin and coat system of a pet includes administering to the pet a nutritional agent which promotes the growth of bifido- and lactic-bacteria in its gastro-intestinal tract. The nutritional agent may be a prebiotic or a probiotic micro-organism, or both. The nutritional agent may be administered together with a long chain fatty acid. | 2010-06-17 |
20100150871 | Genetically-modified strain of yeast with an increased production and output of s-adenosylmethionine (sam) - The invention relates to a genetically-modified strain of yeast, in which the gene coding for adenosine kinase has been inactivated by genetic modification for the production of S-adenosylmethionine (SAM). | 2010-06-17 |
20100150872 | POLYPEPTIDES DERIVED FROM THE HEMOPEXIN-LIKE DOMAIN OF METALLOPROTEINASE MMP-2 - The present invention relates to anti-angiogenic polypeptides derived from the non catalytic C-terminal hemopexin-like domain of the metalloproteinase MMP-2. The invention also provides pharmaceutical compositions comprising said anti-angiogenic polypeptides and methods for using said polypeptide for treating angiogenic diseases, and in particular for treating cancer. | 2010-06-17 |
20100150873 | NOVEL BACTERIA AND USES THEREOF - The present invention relates to a novel bacterium | 2010-06-17 |
20100150874 | PROBIOTICS TO REDUCE DEVELOPMENT OF ALLERGY IN INFANTS BORN BY CAESAREAN SECTION - The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for reducing the risk of subsequent development of allergy in infants delivered by caesarean section. | 2010-06-17 |
20100150875 | INDEFINITE CULTURE OF HUMAN ADULT GLIA WITHOUT IMMORTALIZATION AND THERAPEUTIC USES THEREOF - Cell culture conditions for the isolation, maintenance, and indefinite expansion of human glia are established favoring the growth of neural precursor cells. Cultured cells proliferate indefinitely, express catalytic telomerase, and retain a non-immortalized phenotype. Compositions allow for the indefinite expansion of non-immortalized neural tissue for bioassay applications and restorative neuroscience. | 2010-06-17 |
20100150876 | ENDODERMAL PROGENITOR CELLS - The present invention relates to endodermal progenitor cells and methods of isolation, culture, differentiation and use thereof. | 2010-06-17 |
20100150877 | Osteopontin for the Prediction and Treatment of Cardiovascular Diseases - Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin. | 2010-06-17 |
20100150878 | DERMAL MICRO-ORGANS, METHODS AND APPARATUSES FOR PRODUCING AND USING THE SAME - Embodiments of the present invention provide Dermal Micro-organs (DMOs), methods and apparatuses for producing the same. Some embodiments of the invention provide a DMO including a plurality of dermal components, which substantially retain the micro-architecture and three dimensional structure of the dermal tissue from which they are derived, having dimensions selected so as to allow passive diffusion of adequate nutrients and gases to cells of the DMO and diffusion of cellular waste out of the cells so as to minimize cellular toxicity and concomitant death due to insufficient nutrition and accumulation of waste in the DMO. Some embodiments of the invention provide methods and apparatuses for harvesting the DMO. An apparatus for harvesting the DMO may include, according to some exemplary embodiments, a support configuration to support a skin-related tissue structure from which the DMO is to be harvested, and a cutting tool able to separate the DMO from the skin-related tissue structure. Other embodiments are described and claimed. | 2010-06-17 |
20100150879 | Methods for the detection, isolation, and use of lipid phosphate phosphatase-3-positive stem cells - The present invention embraces antibodies that bind Lipid Phosphate Phosphatase-3, and use thereof in the detection and isolation of stems cells for promoting wound healing, neovascularization, and/or angiogenesis. | 2010-06-17 |
20100150880 | Isolated mesenchymal cell population and method for isolating and using same - The present invention provides a novel isolated mesenchymal cell population of highly purified osteoprogenitors (HipOPs) that can be used in the formation of bone tissue and methods for isolating and using same. | 2010-06-17 |